Description

Volume 64 in the internationally acclaimed Advances in Clinical Chemistry contains chapters authored by world renowned clinical laboratory scientists, physicians and research scientists. The serial provides the latest and most up-to-date technologies related to the field of Clinical Chemistry and is the benchmark for novel analytical approaches in the clinical laboratory.

Key Features

  • Expertise of international contributors
  • Latest cutting-edge technologies
  • Comprehensive in scope

Readership

Clinical Laboratory Professionals, Physicians and Research Scientists

Table of Contents

  • Preface
  • Chapter One: Matrix Metalloproteinases in Coronary Artery Disease
    • Abstract
    • Acknowledgments
    • 1 Introduction
    • 2 Classification, Structure, and Function of MMP
    • 3 Regulation of MMP
    • 4 MMP in Cardiovascular System Development
    • 5 MMP in Coronary Artery Disease
    • 6 Genetics of Matrix Metalloproteinases
    • 7 Matrix Metalloproteinases and Therapeutic Aspects
    • 8 Prognostic Value of ECM Biomarkers
    • 9 Conclusion
  • Chapter Two: Heat Shock Proteins and Cardiovascular Disease
    • Abstract
    • 1 Introduction
    • 2 Atherogenesis and HSP
    • 3 Therapeutic Implications
    • 4 HSPs as Predictors of CVD
    • 5 Immunization and Vaccination with HSP
    • 6 Effects of Therapeutic Interventions on HSP
    • 7 Conclusion
  • Chapter Three: Apolipoprotein B-48: A Unique Marker of Chylomicron Metabolism
    • Abstract
    • Acknowledgment
    • 1 Introduction
    • 2 Discovery of apoB48
    • 3 ApoB48 and mRNA Editing; Stop Codon and Translational Termination of Intestinal apoB mRNA
    • 4 ApoB-48, MTP, and apoA-IV in CM Formation
    • 5 Metabolism of apoB-48 Containing CM, apoB-100 Containing VLDL, and Their Remnants in Plasma
    • 6 Biochemistry of CM and VLDL Remnants
    • 7 ApoB-48 Receptor
    • 8 Kinetics of apoB-48 Containing Lipoproteins
    • 9 Daily Rhythm of Plasma TG, apoB-48, and Remnant Lipoproteins and Their Changes After Fat Load
    • 10 Analytical Approach to apoB48
    • 11 Plasma apoB48 Containing Particles as a Risk Marker for Cardiovascular Diseases
    • 12 Familial Chylomicronemia
    • 13 Prevention of Cardiovascular Disease
    • 14 Treatment of Cardiovascular Disease; Statins, Fibrates, EPA, LPL Gene Therapy
    • 15 Summary
  • Chapter Four: Neutrophil Gelatinase-Associated Lipocalin in Cancer
    • Abstract

Details

No. of pages:
322
Language:
English
Copyright:
© 2014
Published:
Imprint:
Academic Press
Electronic ISBN:
9780128003046
Print ISBN:
9780128002636